References
- 1. Henderson S, Timbs A, McCarthy J, et al. Incidence of haemoglobinopathies in various populations - the impact of immigration. Clin Biochem. 2009; 42(18): 1745-1756.
- 2. Weatherall DJ. Disorders of the synthesis or function of haemoglobin. In: Warrell DA, Cox TM, Firth JD, Benz EJ Jr, Eds. Oxford Textbook of Medicine, 4th ed. Oxford: Oxford University Press. 2003; 676-677.
- 3. Baglioni C. The fusion of two peptide chains in Hemoglobin Lepore and its interpretation as a genetic deletion. Proc Natl Acad Sci USA. 1962; 48(11): 1880-1886.
- 4. Ramirez F, Mears JG, Nudel U, et al. Defects in DNA and globin messenger RNA in homozygotes for Hemoglobin Lepore. J Clin Invest. 1979; 63(4): 736-742.
- 5. Galanello R, Origa R. b-Thalassemia. Orphanet J Rare Dis. 2010;5:11.
- 6. Thein SL, Menzel S, Lathrop M, Garner C. Control of fetal hemoglobin: new insights emerging from genomics and clinical implications. Hum Mol Genet. 2009; 18(R2):R216-R223.
- 7. Efremov DG. Thalassemias and other hemoglobinopathies in the Republic of Macedonia. Hemoglobin. 2007,31(1):1-15.
- 8. Dimovski A, Efremov DG, Jankovic L, et al. b-Thalassemia in Yugoslavia. Hemoglobin. 1990; 14(1): 15-24.
- 9. Efremov GD. b-, db-Thalassemia and Hb Lepore among Yugoslav, Bulgarian, Turkish and Albanian. Haematologica. 1990; 75(Suppl 5): 31-41.
- 10. Petkov GH, Efremov GD, Efremov DG, et al. b- Thalassemia in Bulgaria. Hemoglobin. 1990; 14(1): 25-33.
- 11. Kobayashi M, Rappaport E, Blasband A, et al. Fluorescence-based DNA minisequence analysis for detection of known single-base changes in genomic DNA. Mol Cell Probes. 1995; 9(3): 175-182.
- 12. Galbiati S, Chiari M, Macellari M, Ferrari M, Cremonesi L, Cretich M. High-throughput mutational screening for b-thalassemia by singlenucleotide extension. Electrophoresis. 2007; 28(23): 4289-4294.
- 13. Vrettou C, Traeger-Synodinos J, Tzetis M, Malamis G, Kanavakis E. Rapid screening of multiple bglobin gene mutations by real-time PCR on the LightCycler: application to carrier screening and prenatal diagnosis of thalassemia syndromes. Clin Chem. 2003; 49(5): 769-776.
- 14. Huisman THJ, Carver MFH, Baysal E. A Syllabus of Thalassemia Mutations (1997). Augusta: The Sickle Cell Anemia Foundation, 1997.
- 15. Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004; 32(Suppl 1): D537-D541.
- 16. Samperi P, Mancuso GR, Dibenedetto SP, Di Cataldo A, Ragusa R, Schilirò G. High performance liquid chromatography (HPLC): a simple method to quantify Hb C, O-Arab, Agenogi and F. Clin Lab Haematol. 1991; 13(2): 169-75.
- 17. Malamos B, Fessas P, Stamatoyannopoulos G. Types of thalassaemia trait carriers as revealed by a study of their incidence in Greece. Br J Haematol. 1964; 8(1): 5-14.